---
$id: https://graph.org.ai/products/commodity/51263306
$type: Product
source: UNSPSC
code: "51263306"
title: "Dioxadilol"
class: "51263300"
classTitle: "Adrenergic blocking agents, synthesized"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dioxadilol

**UNSPSC Code**: 51263306
**Class**: [Adrenergic blocking agents, synthesized](Adrenergic blocking agents, synthesized.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G25Z4785LV, chemically known as (- )-1-(1,4-benzodioxan-2-ylmethoxy)-3-(tert-butylamino)-2-propanol. but generally known as dioxadilol, which bears US NIH Compound Identifier 208844. European Medicines Agency schedules Dioxadilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07199MIG. The term DIOXADILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). DIOXADILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dioxadilol under HS 29329985 and SITC 51569. As of Q4 2014, DIOXADILOL remains the US FDA Preferred Term for this commodity. Dioxadilol bears US NLM identifiers UMLS ID C1880338 and NCI Concept Code C65414. SMILES: O(CC(O)CNC(C)(C)C)CC1OC2C(OC1)CCCC2.

